Fund Insights
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Novanta
NOVT
Market cap
$3.65B
Overview
Fund Trends
Analyst Outlook
Journalist View
101.40
USD
+1.44
1.44%
At close
Updated
Oct 13, 1:47 PM EDT
Pre-market
After hours
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
1.44%
5 days
-3.54%
1 month
-10.88%
3 months
-19.92%
6 months
-11.43%
Year to date
-32.82%
1 year
-42.53%
5 years
-11.63%
10 years
577.35%
Positive
Neutral
Negative
Neutral
Business Wire
5 days ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 4, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2025 results on Tuesday, November 4, 2025. The Company will host a conference call on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a.
Neutral
Business Wire
25 days ago
Novanta's Board of Directors Authorizes Additional $200 Million for Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directors has authorized the repurchase of up to an additional $200 million of the Company's outstanding common shares, adding capacity to the $31 million remaining from its 2020 Board authorization, for a total capacity of $231 million. “The Board's action reflects continued confidence in the Company's f.
Neutral
Business Wire
2 months ago
Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life.
Neutral
The Motley Fool
2 months ago
Novanta (NOVT) Q2 Revenue Rises 2.2%
Novanta (NOVT) Q2 Revenue Rises 2.2%
Neutral
Seeking Alpha
2 months ago
Novanta Inc. (NOVT) Q2 2025 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT ) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ET Company Participants Matthijs Glastra - CEO & Chairman of the Board Ray Nash - Corporate Participant Corporate Finance Leader & IR - Corporate Participant Robert J. Buckley - Chief Financial Officer Conference Call Participants Brian Paul Drab - William Blair & Company L.L.C.
Positive
Zacks Investment Research
2 months ago
Novanta (NOVT) Q2 Earnings and Revenues Top Estimates
Novanta (NOVT) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.73 per share a year ago.
Neutral
Business Wire
2 months ago
Novanta Announces Financial Results for the Second Quarter 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) June 27, June 28, 2025 2024 GAAP Revenue $ 241.0 $ 235.9 Operating Income $ 14.9 $ 25.7 Net Income $ 4.5 $ 13.8 Diluted EPS $ 0.12 $ 0.38.
Neutral
Business Wire
3 months ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 results on Tuesday, August 5, 2025. The Company will host a conference call on Tuesday, August 5, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a li.
Neutral
Business Wire
4 months ago
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025, in White Plains, New York. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial.
Neutral
Business Wire
5 months ago
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial orig.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close